当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Ian Bricknell
As a implicit treatment for a number of neurological conditions, the sesquiterpene bilobalide (BB), which was insulated from Ginkgo biloba excerpt, has entered a lot of attention. Demyelination and axonal degeneration are emblems of the habitual vulnerable- mediated seditious and neurodegenerative complaint known as Multiple Sclerosis (MS). The stylish imitator of MS is Experimental Autoimmune Encephalomyelitis (EAE), which is considerably studied for MS exploration and is characterized by T cell and macrophage infiltration, severe demyelination, and neuroinflammation. substantiation that bilobalide (BB) defended the myelin jacket through immunomodulation, antiinflammation, and anti-apoptosis is presented in the most recent paper," The remedial eventuality of bilobalide on Experimental Autoimmune Encephalomyelitis( EAE) mice." We talked about the goods of BB treatment on EAE in this review.